Mural Oncology plc (MURA) — Cash Flow-to-Debt Ratio
Latest as of September 2025:
-1.75x
Mural Oncology plc (MURA) has a Cash Flow-to-Debt Ratio of -1.75x as of September 2025, meaning its operating cash flow of $-18.48 Million could theoretically repay -2% of its total liabilities ($10.57 Million) in one year. Explore MURA cash generation efficiency to assess how effectively this company generates cash.
CF-to-Debt Ratio
-1.75x
Operating CF / Total Liabilities
Operating Cash Flow
$-18.48 Million
USD
Total Liabilities
$10.57 Million
USD
Data as of
Sep 2025
Most recent filing
Mural Oncology plc Cash Flow-to-Debt Ratio (2021–2024)
Historical debt coverage capacity for Mural Oncology plc across 4 annual periods. Also explore MURA current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Mural Oncology plc (2021–2024)
Year-by-year debt coverage analysis for Mural Oncology plc. For market capitalisation and broader financial context, see MURA market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -4.45x | $-128.54 Million | $28.89 Million | ▲ +13.1% |
| 2023 | -5.12x | $-194.25 Million | $37.93 Million | ▼ -68.3% |
| 2022 | -3.04x | $-168.59 Million | $55.41 Million | ▼ -2.9% |
| 2021 | -2.96x | $-156.67 Million | $52.99 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.